Cystic fibrosis

• Spirovant Sciences

  Company1 trialPhase 1/215 people

• Vertex Pharmaceuticals

  Company1 trialPhase 118 people

• Emory University

  4 trialsPhase 4181 people

• University of Texas Southwestern Medical Center

  1 trialPhase 4100 people

• Johns Hopkins University

  1 trialPhase 475 people

• McMaster University

  1 trialPhase 456 people

• Hospital Infantil de Mexico Federico Gomez

  1 trialPhase 440 people

• University Hospital, Ghent

  1 trialPhase 419 people

National Institute of Diabetes and Digestive and Kidney DiseasesUS$617.4kNational Heart, Lung, and Blood InstituteUS$611.1k

• Targeting SGLTs for liver disease in a rabbit model of cystic fibrosis

  National Institute of Diabetes and Digestive and Kidney DiseasesUniversity of Michigan at Ann ArborUS$617.4k2023–2027

• Epigenetic Modulation of Cellular Senescence in the Cystic Fibrosis Lung

  National Heart, Lung, and Blood InstituteOld Dominion UniversityUS$611.1k2024–2028